Brand-name drug
Brilinta price, strengths & recalls
Brand of ticagrelor (generic)
Pharmacies pay $222.45 for 30 tablets of Brilinta 90 mg tablet this week, and from $222.45 to $222.52 across its 2 priced strengths and forms. The generic, ticagrelor, costs pharmacies from $7.29. It has 2 recalls on record, none ongoing. Its official label last changed on August 7, 2026.
Brand- Fair cash price
- $266.32
- Strengths
- 2
- Makers
- 1
- Updated
- Nov 11
Brilinta price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 60 mg tablet Brand | $7.42 | $222.52 / 30 tablets |
| 90 mg tablet Brand | $7.42 | $222.45 / 30 tablets |
Brilinta vs generic ticagrelor
Generics have the same active ingredient, strength and form, and FDA requires them to work the same way. What pharmacies pay for each, same quantity:
GenericTicagrelor pricesSupply status: shortages & recalls
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Brilinta
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use BRILINTA safely and effectively. See full prescribing information for BRILINTA.BRILINTA® (ticagrelor) tablets, for oral useInitial U.S. Approval: 2011
WARNING: BLEEDING RISK
•
BRILINTA, like other antiplatelet agents, can cause significant, sometimes fatal bleeding (5.1, 6.1).
•
Do not use BRILINTA in patients with active pathological bleeding or a history of intracranial hemorrhage
•
(4.1, 4.2).
•
Do not start BRILINTA in patients undergoing urgent coronary artery bypass graft surgery (CABG) (5.1,
•
6.1).
•
If possible, manage bleeding without discontinuing BRILINTA. Stopping BRILINTA increases the risk of
•
subsequent cardiovascular events (5.2).
WARNING: BLEEDING RISK
See full prescribing information for complete boxed warning.
•
BRILINTA, like other antiplatelet agents, can cause significant,
•
sometimes fatal bleeding. (5.1, 6.1)
•
Do not use BRILINTA in patients with active pathological
•
bleeding or a history of intracranial hemorrhage. (4.1, 4.2)
•
Do not start BRILINTA in patients undergoing urgent coronary
•
artery bypass graft surgery (CABG). (5.1, 6.1)
•
If possible, manage bleeding without discontinuing BRILINTA.
•
Stopping BRILINTA increases the risk of subsequent
•
cardiovascular events. (5.2)
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA022433 · Astrazeneca
- First approved
- July 20, 2011 (15 years ago)
- Latest approved change
- May 7, 2026
- Approved label
- PDF, May 18, 2026
- Generic makers
- 16 approved generic applications on the market
- Last patent listed
- July 27, 2036
Brilinta questions
How much does brilinta cost without insurance?
Pharmacies pay about $222.45 for 30 tablets of brilinta 90 mg tablet ($7.42 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $266.32. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is there a generic for Brilinta?
Yes: ticagrelor. Pharmacies pay from $7.29 for it. Compare ticagrelor prices.
Is brilinta in shortage?
No shortage is reported for brilinta right now. We check the national shortage list every day.
Has brilinta been recalled?
2 recalls on record, none ongoing. Recalls name specific lots - check yours.
When did the brilinta label last change?
The official label was last updated on August 7, 2026 (version 56). See what changed.
Talk about brilinta
No comments yet. Questions, tips, what worked for you - start the conversation.